Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that Harel Gadot, CEO, President and Chairman, will be a featured ...
Microbot Medical Inc. MBOT shares are up on Tuesday following the announcement that Tampa General Hospital has become the ...
(Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced today that Tampa General Hospital has become the first health system in Florida to adopt ...
HINGHAM, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that LIBERTY was ...
The average one-year price target for Microbot Medical (NasdaqCM:MBOT) has been revised to $6.80 / share. This is a decrease of 11.11% from the prior estimate of $7.65 dated February 1, 2026. The ...
Microbot Medical to Unveil World’s First Fully Disposable Robotic System for Endovascular Procedures
“LIBERTY is set to revolutionize the way surgical robotics are being used in endovascular procedures, by eliminating the need for capital equipment, reducing radiation exposure and aiming to ...
Microbot Medical Inc. has announced the addition of two senior executives to enhance its U.S. commercial leadership team in preparation for the upcoming launch of its LIBERTY® Endovascular Robotic ...
Microbot shares are trading higher Monday after the company received FDA approval to proceed with its human clinical trial. Microbot says the study will be conducted in the U.S., and it has already ...
Microbot Medical Inc (NASDAQ:MBOT) shares are trading higher by 22% to $2.58 during Monday’s session after the company announced it sold 4.26 million shares under an ATM agreement and generated $4.82 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results